|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Oyster Point Pharma, Inc. (OYST) |
|
|
$11.17 0.00 (0.00%) as of 4:30 Fri 12/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
21,360,000 |
| Market
Cap: |
238.59(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$11.17 - $11.17 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Oyster Point Pharma is a biopharmaceutical company focused on the discovery, development and commercialization of pharmaceutical therapies to treat ophthalmic diseases. Co.'s development pipeline includes: Small Molecule Programs, which consist of Tyrvaya™ (varenicline solution) Nasal Spray for the indication of dry eye disease, and OC-01 (varenicline solution) nasal spray for the indication of Neurotrophic Keratopathy Stage 1; and ETF™ Gene Therapy Approach, which consists of OC-101 adeno-associated virus (AAV)-Nerve Growth Factor for the indication of Neurotrophic Keratopathy Stage 2 and 3, and OC-103 AAV for the indication of Vernal Keratoconjunctivitis/Severe Allergic Conjunctivitis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nau Jeffrey |
President and CEO |
• • – |
2021-10-21 |
4 |
OE |
$1.02 |
$51,000 |
D/D |
50,000 |
110,898 |
|
- |
|
| Versant Side Fund Iv, L.p. |
10% Owner |
– – • |
2021-10-18 |
4 |
AS |
$14.63 |
$8,160,736 |
I/I |
(550,000) |
4,987 |
|
-35% |
|
| Link William J Phd |
Director |
– • – |
2021-10-18 |
4 |
AS |
$14.63 |
$8,160,736 |
I/I |
(550,000) |
4,987 |
|
-35% |
|
| Clare Ozawa |
Director |
– • • |
2021-10-18 |
4 |
AS |
$14.63 |
$8,160,736 |
I/I |
(550,000) |
4,987 |
|
-35% |
|
| Lochner Daniel |
Chief Financial Officer |
• – – |
2021-09-02 |
4 |
OE |
$11.51 |
$86,325 |
D/D |
7,500 |
49,631 |
|
- |
|
| Nau Jeffrey |
President and CEO |
• • – |
2021-09-01 |
4 |
OE |
$1.02 |
$10,200 |
D/D |
10,000 |
60,898 |
|
- |
|
| Santel Donald J |
Director |
– • – |
2021-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,114 |
10,114 |
|
- |
|
| Lochner Daniel |
Chief Financial Officer |
• – – |
2021-07-28 |
4 |
OE |
$11.51 |
$86,325 |
D/D |
7,500 |
42,131 |
|
- |
|
| Weisner Aimee S |
Director |
– • – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
33,191 |
|
- |
|
| Behbahani Ali |
Director |
– • – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
10,066 |
|
- |
|
| Atieh Michael G |
Director |
– • – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
23,161 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
10,066 |
|
- |
|
| Murray Mark Anthony |
Director |
– • – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
118,513 |
|
- |
|
| Clare Ozawa |
Director |
– • – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
10,824 |
|
- |
|
| Tsai Benjamin |
Director |
– • – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
10,066 |
|
- |
|
| Eliades George Christopher |
Director |
– • – |
2021-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
25,051 |
|
- |
|
| Versant Side Fund Iv, L.p. |
10% Owner |
– – • |
2021-05-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(404,844) |
8,430 |
|
- |
|
| Versant Side Fund Iv, L.p. |
10% Owner |
– – • |
2021-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
82,486 |
82,486 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2021-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
10,944 |
1,273 |
|
- |
|
| Clare Ozawa |
Director |
– • • |
2021-05-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(404,844) |
8,430 |
|
- |
|
| Clare Ozawa |
Director |
– • • |
2021-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
193 |
7,358 |
|
- |
|
| Clare Ozawa |
Director |
– • • |
2021-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
82,486 |
82,486 |
|
- |
|
| Nau Jeffrey |
President and CEO |
• • – |
2021-04-02 |
4 |
OE |
$1.02 |
$10,200 |
D/D |
10,000 |
50,898 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2021-03-26 |
4 |
A |
$0.00 |
$0 |
I/I |
10,933 |
631 |
|
- |
|
| Versant Side Fund Iv, L.p. |
10% Owner |
– – • |
2021-03-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(404,849) |
10,448 |
|
- |
|
140 Records found
|
|
Page 3 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
